During the past decade, Alabama Liver and Digestive Specialists conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Alabama Liver and Digestive Specialists" are "Hepatitis C, Chronic" (2 trials), "Hepatitis C Virus" (1 trials), "Inflammatory Bowel Disease" (1 trials) and "Small Bowel Disease" (1 trials). Many other conditions were trialed in "Alabama Liver and Digestive Specialists" in a lesser frequency.

Most popular intervention types in "Alabama Liver and Digestive Specialists" are "Drug" (3 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Copegus®" (1 trials), "GS-5885 tablet" (1 trials), "GS-9451" (1 trials), "GS-9451 placebo" (1 trials) and "GS-9451 tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alabama Liver and Digestive Specialists" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Alabama Liver and Digestive Specialists". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Alabama Liver and Digestive Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Alabama Liver and Digestive Specialists, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".